395 F.3d 1364 (Fed. Cir. 2005), 04-1005, Merck & Co., Inc. v. Teva Pharmaceuticals USA, Inc.
Linked as:
Extract
395 F.3d 1364 (Fed. Cir. 2005), 04-1005, Merck & Co., Inc. v. Teva Pharmaceuticals USA, Inc.
No longer available (Autolink)
See the full content of this document
This document cites
- US Code - 35 U.S.C. § 102 Conditions For Patentability; Novelty
- US Code - 35 U.S.C. § 103 Conditions For Patentability; Non-Obvious Subject Matter
- US Code - 35 U.S.C. § 271 Infringement of Patent
- US Code - 28 U.S.C. § 1295 Jurisdiction of the United States Court of Appeals For the Federal Circuit
- R. v. Black, (1989) 98 N.R. 281 (SCC)
